Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLL-Frail - A Prospective, Multicenter Phase II Trial of Acalabrutinib in Very Old (≥80y) or Frail CLL-Patients

NCT04883749 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT04883749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04883749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLL-Frail - A Prospective, Multicenter Phase II Trial of Acalabrutinib in Very Old (≥80y) or Frail CLL-Patients
Lead sponsor
German CLL Study Group
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2021
Completion date
May 8, 2025
Enrollment
53 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphoid leukemia